tiprankstipranks
Trending News
More News >
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market

Acumen Pharmaceuticals (ABOS) Ratios

Compare
416 Followers

Acumen Pharmaceuticals Ratios

ABOS's free cash flow for Q3 2024 was $0.00. For the 2024 fiscal year, ABOS's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.46 19.01 23.08 38.60 6.98
Quick Ratio
6.46 19.01 23.08 38.60 6.98
Cash Ratio
1.29 5.16 16.65 23.73 6.88
Solvency Ratio
-1.79 -1.21 -5.16 -35.30 <0.01
Operating Cash Flow Ratio
-3.12 -3.32 -4.50 -3.49 -1.17
Short-Term Operating Cash Flow Coverage
0.00 -49.73 -334.79 0.00 0.00
Net Current Asset Value
$ 121.13M$ 203.46M$ 172.52M$ 193.51M$ -18.59M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.09 <0.01 0.00 0.00
Debt-to-Equity Ratio
0.00 0.11 <0.01 0.00 0.00
Debt-to-Capital Ratio
0.00 0.10 <0.01 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.09 0.00 0.00 0.00
Financial Leverage Ratio
1.31 1.16 1.04 1.02 -2.39
Debt Service Coverage Ratio
28.03 -59.59 -383.87 0.00 0.00
Interest Coverage Ratio
28.03 0.00- 0.00 0.00
Debt to Market Cap
0.00 0.15 <0.01 0.00 0.00
Interest Debt Per Share
-0.07 0.59 <0.01 0.00 0.00
Net Debt to EBITDA
0.31 0.74 3.05 -1.98 -74.58
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%99.44%
EBIT Margin
0.00%0.00%0.00%0.00%-550.97%
EBITDA Margin
0.00%0.00%0.00%0.00%40.88%
Operating Profit Margin
0.00%0.00%0.00%0.00%-550.97%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-510.10%
Net Profit Margin
0.00%0.00%0.00%0.00%-510.03%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-510.10%
Net Income Per EBT
100.00%100.00%94.44%180.58%99.99%
EBT Per EBIT
89.75%85.66%94.74%-163.39%92.58%
Return on Assets (ROA)
-42.82%-16.89%-20.59%-78.88%-16.48%
Return on Equity (ROE)
-56.28%-19.62%-21.44%-80.68%39.40%
Return on Capital Employed (ROCE)
-53.94%-20.57%-23.96%27.34%-20.79%
Return on Invested Capital (ROIC)
-53.94%-20.46%-22.61%49.38%-20.78%
Return on Tangible Assets
-42.82%-16.89%-20.59%-78.88%-16.48%
Earnings Yield
-99.13%-28.13%-18.46%-66.40%-0.91%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 13.17
Payables Turnover
0.00 0.13 0.10 <0.01 0.02
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.03
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 0.07
Cash Conversion Cycle
0.00 -2.74K -3.54K -99.28K -24.21K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 27.71
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 2.74K 3.54K 99.28K 24.24K
Operating Cycle
0.00 0.00 0.00 0.00 27.71
Cash Flow Ratios
Operating Cash Flow Per Share
-1.44 -0.89 -0.87 -0.44 -0.19
Free Cash Flow Per Share
-1.44 -0.89 -0.87 -0.44 -0.19
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-5.39K -2.05K -218.34 -449.02 0.00
Capital Expenditure Coverage Ratio
-5.39K -2.05K -218.34 -449.02 0.00
Operating Cash Flow Coverage Ratio
0.00 -1.51 -334.79 0.00 0.00
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 -5.19
Free Cash Flow Yield
-83.54%-23.14%-16.11%-6.58%-0.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.01 -3.56 -5.42 -1.51 -110.19
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 562.01
Price-to-Book (P/B) Ratio
0.57 0.70 1.16 1.22 -43.41
Price-to-Free Cash Flow (P/FCF) Ratio
-1.20 -4.32 -6.21 -15.20 -108.33
Price-to-Operating Cash Flow Ratio
-1.20 -4.32 -6.24 -15.23 -108.33
Price-to-Earnings Growth (PEG) Ratio
-0.02 -0.44 0.07 >-0.01 11.02
Price-to-Fair Value
0.57 0.70 1.16 1.22 -43.41
Enterprise Value Multiple
-0.59 -2.86 -2.09 2.46 1.30K
EV to EBITDA
-0.59 -2.86 -2.09 2.46 1.30K
EV to Sales
0.00 0.00 0.00 0.00 531.53
EV to Free Cash Flow
-0.78 -3.43 -2.53 -8.41 -102.45
EV to Operating Cash Flow
-0.78 -3.43 -2.54 -8.43 -102.45
Tangible Book Value Per Share
3.03 5.51 4.65 5.56 -0.46
Shareholders’ Equity Per Share
3.03 5.51 4.65 5.56 -0.46
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.06 -0.81 <0.01
Revenue Per Share
0.00 0.00 0.00 0.00 0.04
Net Income Per Share
-1.71 -1.08 -1.00 -4.49 -0.18
Tax Burden
1.00 1.00 0.94 1.81 1.00
Interest Burden
0.96 1.01 1.00 1.00 0.93
Research & Development to Revenue
0.00 0.00 0.00 0.00 5.57
SG&A to Revenue
0.00 0.00 0.00 0.00 0.94
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.11
Income Quality
0.84 0.82 0.82 0.18 1.02
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis